Atlas Trials

Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma

Clinical trial NCT04898374 · UNKNOWN

Trial details

NCT number
NCT04898374
Sponsor
Kuwait Cancer Control Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2021-05-01
Primary completion
2025-04-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.